NCT03054844View on ClinicalTrials.gov

PREMIX vs PREMED Intranasal Lidocaine and Midazolam

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

April 3, 2017

Primary Completion Date

October 10, 2017

Study Completion Date

October 10, 2017

Conditions
Pain
Interventions
DRUG

Lidocaine

Lidocaine will be administered before administration of midazolam.

DRUG

Lidocaine and midazolam (PREMIX)

Lidocaine will be administered as a mixture with midazolam.

DRUG

Midazolam

Midazolam will be administered either after lidocaine, or as a mixture with lidocaine.

Trial Locations (1)

10032

Morgan Stanley Children's Hospital, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT03054844 - PREMIX vs PREMED Intranasal Lidocaine and Midazolam | Biotech Hunter | Biotech Hunter